Tradestie Institutional Equity Comparison Engine

AXNX vs ATRC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATRC Overall Edge

ATRC Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AtriCure, Inc. (ATRC) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ATRC at 122.1x Forward P/E and 2.9% operating margin (+15.0% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ATRC sits in UNCLASSIFIED (74th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ATRC
AXNX N/M vs ATRC 122.1x Fwd P/E
Growth & Margin Winner ATRC
Op Margin N/A vs 2.9% ยท YoY N/A vs +15.0%
Momentum & Technical Winner ATRC
1Y +16.9% vs +62.0% ยท 52W Pos 50% vs 74%
Options & Structure Winner ATRC
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (74th %ile IV)
AXNX US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap N/A
1M Return -26.54%
1Y Return +16.92%
Forward P/E N/M
Unified AI Score
52.1 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
ATRC NASDAQ
AtriCure, Inc.
Surgical & Medical Instruments & Apparatus
$55.39
+2.37% 1D
Market Cap $2.8B
1M Return -6.59%
1Y Return +62.05%
Forward P/E 122.1x
Unified AI Score
53.7 / 100 HOLD
Tech 42.0 Fund 47.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AXNX +16.92% ATRC +62.05% Spread: +19.52 pp (AXNX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AXNX TTM Op. Margin: N/A ATRC TTM Op. Margin: 2.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs ATRC. Trailing 12-month operating profitability (AXNX N/A vs ATRC 2.9%) and valuation multiples (AXNX N/M vs ATRC 122.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AXNX (0) vs ATRC (9)
Institutional Metric AXNX ATRC Criterion Row Winner
Market Capitalization Scale N/A $2.8B Larger Scale ATRC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M 122.1x Lower Multiple ATRC
Revenue Growth (YoY) Growth N/A +15.0% Higher Growth ATRC
Operating Margin (TTM) Profitability N/A 2.9% Higher Margin ATRC
Net Profit Margin Profitability N/A 2.5% Higher Margin ATRC
Return on Equity (ROE) Capital Efficiency N/A 2.9% Higher ROE ATRC
52-Week Range Position Momentum 50% ($0โ€“$1) 74% ($25โ€“$66) Stronger Trend ATRC
Beta / 30D Volatility Risk Regime N/A 0.47ฮฒ ยท 49% Vol Lower Realized Risk ATRC
Unified Institutional Score Composite Signal 52.1 / 100 (HOLD) 53.7 / 100 (HOLD) Higher Composite ATRC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AXNX vs ATRC Buy Guide
AXNX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AXNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATRC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 74th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live ATRC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AXNX nor ATRC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.